Education
About Us
Working with TipRanks
Follow Us
Nanologica AB (SE:NICA)
:NICA
NICA Stock Chart & Stats
kr0.75
kr0.03(1.43%)
At close: 4:00 PM EST
kr0.75
kr0.03(1.43%)
Day’s Range― - ―
52-Week Rangekr0.68 - kr2.50
Previous CloseN/A
Volume105.00
Average Volume (3M)111.94K
Market Cap
kr65.91M
Enterprise Valuekr82.85M
Total Cash (Recent Filing)kr13.97M
Total Debt (Recent Filing)kr19.71M
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Feb 12, 2026EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding88,357,230
10 Day Avg. Volume89,035
30 Day Avg. Volume111,941
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.22
Price to Sales (P/S)6.20
P/FCF Ratio-1.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanologica AB News
NICA FAQ
What was Nanologica AB’s price range in the past 12 months?
Nanologica AB lowest stock price was kr0.68 and its highest was kr2.50 in the past 12 months.
What is Nanologica AB’s market cap?
Nanologica AB’s market cap is kr65.91M.
When is Nanologica AB’s upcoming earnings report date?
Nanologica AB’s upcoming earnings report date is Feb 12, 2026 which is in 56 days.
How were Nanologica AB’s earnings last quarter?
Nanologica AB released its earnings results on Oct 23, 2025. The company reported -kr0.1 earnings per share for the quarter, beating the consensus estimate of -kr0.2 by kr0.1.
Is Nanologica AB overvalued?
According to Wall Street analysts Nanologica AB’s price is currently Overvalued.
Does Nanologica AB pay dividends?
Nanologica AB does not currently pay dividends.
What is Nanologica AB’s EPS estimate?
Nanologica AB’s EPS estimate is -0.1.
How many shares outstanding does Nanologica AB have?
Nanologica AB has 88,357,230 shares outstanding.
What happened to Nanologica AB’s price movement after its last earnings report?
Nanologica AB reported an EPS of -kr0.1 in its last earnings report, beating expectations of -kr0.2. Following the earnings report the stock price went down -7.746%.
Which hedge fund is a major shareholder of Nanologica AB?
Currently, no hedge funds are holding shares in SE:NICA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nanologica AB
Nanologica AB (NICA) is a Swedish biotechnology company specializing in the development and commercialization of innovative nanoparticle-based technologies for drug delivery and diagnostics. The company focuses on the pharmaceutical and healthcare sectors, leveraging its proprietary nanoparticle platform to enhance the efficacy of existing therapies and improve patient outcomes. Nanologica's core products include advanced drug delivery systems and diagnostic solutions that utilize its unique nanoscale materials.
Technical Analysis
Alzinova AB
―
Biosergen AB
―
Biovica International AB Class B
―
NextCell Pharma AB
―
Spago Nanomedical AB
―